STAG2 is expressed broadly in many different cell types, and yet STAG2 mutation is especially frequent in certain malignancies, including bladder cancer, uterine cancer, and Ewing sarcoma [53]. This evidence concerns the gene STAG2 and urinary bladder cancer.